Moderna
Trade Moderna 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.
MRNA Key Statistics
Stock Snapshot
As of today, Moderna(MRNA) shares are valued at $220.99. The company's market cap stands at 90.37B, with a P/E ratio of -28.34.
As of 2026-10-15, Moderna(MRNA) stock has fluctuated between $220.01 and $222.00. The current price stands at $220.99, placing the stock +0.4% above today's low and -0.5% off the high.
The Moderna(MRNA)'s current trading volume is 127.3K, compared to an average daily volume of 18.77M.
During the past year, Moderna(MRNA) stock moved between $22.28 at its lowest and $227.46 at its peak.
During the past year, Moderna(MRNA) stock moved between $22.28 at its lowest and $227.46 at its peak.
MRNA News
Goldman Sachs analyst Salveen Richter raised the firm’s price target on Moderna (MRNA) to $137 from $120 and keeps a Neutral rating on the shares. Moderna’s det...
Moderna (MRNA) just joined the NASDAQ-100 Index. This move can reshape how large institutional investors treat the stock and influence how you think about its r...
Shares of Moderna (MRNA Quick QuoteMRNA - Free Report) have gained more than 5% over the past week, adding roughly $4.2 billion in market value. The upsi...
Analyst ratings
56%
of 27 ratingsMore MRNA News
Can the pioneer of mRNA vaccines outpace the king of cystic fibrosis treatments? Choosing between Moderna (MRNA -5.00%) and Vertex Pharmaceuticals (VRTX -0.60%)...
For the first nearly eight months of 2026, Moderna (MRNA -5.00%) and BioNTech SE (BNTX -1.16%) had similar market caps. The two stocks exchanged the edge multip...
Moderna’s very large year to date surge on the back of fresh cancer vaccine data has turned mRNA oncology from a niche science story into front-page investing d...
In the latest close session, Moderna (MRNA Quick QuoteMRNA - Free Report) was down 5.05% at $213.63. The stock fell short of the S&P 500, which registered...
Notable profits for the buyer who lifted the $5.00 offer for 1,010 Moderna (MRNA) Oct-26 220 calls yesterday at 09:39ET when underlying shares were trading at $...
has delivered a very strong run over the past year, which now puts the focus squarely on whether the current share price is properly supported by its sales base...
Moderna (MRNA +14.21%) has been one of the market's hottest stocks this year, surging more than 500% so far. The biotech stock has delivered these kinds of gain...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.